#United States #New York #Class Action #Gross Law Firm #Cardlytics

Class Action Lawsuit Against Cardlytics, Inc.

In a recent announcement, The Gross Law Firm has notified shareholders of Cardlytics, Inc. (NASDAQ: CDLX) about an ongoing class action lawsuit. This notice is particularly significant for investors who purchased shares of Cardlytics during the designated class period, which runs from March 14, 2024, to August 7, 2024. The law firm encourages affected shareholders to step forward, especially those interested in potentially becoming lead plaintiffs in the legal proceedings.

Key Details of the Lawsuit

Allegations

The lawsuit accuses Cardlytics of making materially false or misleading statements during the aforementioned class period. Specifically, the complaints highlight several critical issues:
1. Consumer Engagement and Incentives: The allegations suggest that an increase in consumer engagement led to higher consumer incentives, yet Cardlytics failed to manage this situation effectively.
2. Revenue Growth Problems: The company purportedly could not align its revenue growth with rising consumer engagement rates, posing a significant risk to its financial performance.
3. Operational Issues: Changes to its Ads Decision Engine, meant to boost consumer engagement, reportedly caused discrepancies in budget delivery and billing estimates for customers.
4. Misleading Communication: The firm claims that all of these issues rendered the positive representations from Cardlytics regarding its operations and future outlook misleading or lacking a reasonable foundation.

Deadline for Shareholders

Shareholders are urged to act swiftly. The deadline to register for the class action is set for March 25, 2025. This registration is crucial, as it allows shareholders to stay informed about the legal proceedings and receive updates on the case's status. Importantly, joining the lawsuit as a lead plaintiff is not a prerequisite for participating in any potential recovery from the case.

What to Do Next?

If you are a shareholder who acquired shares of Cardlytics during the designated timeframe, it is essential to register your information with The Gross Law Firm. By doing so, you will gain access to a portfolio monitoring tool that will keep you updated throughout the process. Interested parties can complete the registration form available on the law firm’s website.

Why Choose The Gross Law Firm?

The Gross Law Firm has established a reputation as a nationally recognized class action law firm dedicated to defending the rights of investors. Their mission is to aid individuals who have suffered financial losses due to fraudulent and deceptive corporate practices. They ensure that companies adhere to responsible business standards and strive for ethical corporate governance. The firm emphasizes recovery for investors harmed by misleading corporate communications that artificially inflated stock prices.

Contact Information

For more details, shareholders can contact The Gross Law Firm directly:

• - Address: 15 West 38th Street, 12th Floor, New York, NY, 10018
• - Phone: (646) 453-8903
• - Email: [email protected]

By joining this class action, affected shareholders have an opportunity to hold Cardlytics accountable for any missteps or misinformation that negatively impacted their investments. Don’t miss the March 25 deadline—take action today to safeguard your interests.